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Thelper (Th) 17 cells havebeen recently discovered in
both mouse and human. Here we show that inter-
leukin-1 (IL-1) signaling on T cells is critically required
for the early programming of Th17 cell lineage and
Th17 cell-mediated autoimmunity. IL-1 receptor1
expression in T cells, which was induced by IL-6,
wasnecessary for the inductionof experimental auto-
immune encephalomyelitis and for early Th17 cell
differentiation in vivo. Moreover, IL-1 signaling in
T cells was required in dendritic cell-mediated Th17
cell differentiation from naive or regulatory precur-
sors and IL-1 synergized with IL-6 and IL-23 to regu-
late Th17 cell differentiation and maintain cytokine
expression in effector Th17 cells. Importantly, IL-1
regulated the expression of the transcription factors
IRF4andRORgt duringTh17cell differentiation; over-
expression of these two factors resulted in IL-1-inde-
pendent Th17 cell polarization. Our data thus indicate
a critical role of IL-1 in Th17 cell differentiation and
this pathway may serve as a unique target for Th17
cell-mediated immunopathology.
INTRODUCTION
Th17 cells are a unique lineage of T cells that have been shown to
be important in autoimmunity and clearance ofmucosal infection
by producing proinflammatory cytokines IL-17, IL-17F, and IL-22
(Dong, 2008; Ouyang et al., 2008). Compared with other Th cell
lineages, Th17 cells have unique genetic programs. The tran-
scription factor STAT3 is essential for Th17 cell differentiation
in mouse and human possibly via induction of two orphan
nuclear receptors RORgt and RORa (Laurence et al., 2007; Ma
et al., 2008; Milner et al., 2008; Yang et al., 2007, 2008b). RORgt
was first identified as a Th17 cell-specific transcription factor
that is sufficient and necessary for Th17 cell differentiation (Iva-
nov et al., 2006). RORa plays a synergistic and somewhat redun-
dant function with RORgt during Th17 cell polarization (Yang
et al., 2008c). Interferon regulatory factor 4 (IRF4) was originally
reported to be important in Th2 cell differentiation (Lohoff et al.,
2002; Rengarajan et al., 2002). However, a recent study revealed576 Immunity 30, 576–587, April 17, 2009 ª2009 Elsevier Inc.that IRF4-deficient T cells are completely impaired in Th17 cell
polarization. Indeed, IRF4-deficient mice are resistant to induc-
tion of Th17 cell-mediated experimental autoimmune encepha-
lomyelitis (EAE) (Brustle et al., 2007). An environmental toxin
sensor, aryl hydrocarbon receptor (Ahr), was found to be highly
expressed in Th17 and regulatory T (Treg) cells and to regulate
Th17 cytokine production, especially IL-22 (Quintana et al.,
2008; Veldhoen et al., 2008). In contrast, the regulatory T cell
transcription factor Foxp3 inhibits Th17 cell polarization by
binding to RORgt and RORa to inhibit their transcriptional
activity (Yang et al., 2008b; Zhou et al., 2008).
IL-6 and transforming growth factor-b (TGF-b) have been
reportedas theminimal requirements formurineTh17cell differen-
tiation fromnaive CD4+ T cells (Bettelli et al., 2006; Veldhoen et al.,
2006). During Th17 cell differentiation initiated by TGF-b and IL-6,
IL-1appears toplayanaccessory role (Veldhoenetal., 2006). IL-21
induced by IL-6 acts in an autocrine fashion and drives Th17 cell
generation together with TGF-b (Korn et al., 2007; Nurieva et al.,
2007; Zhou et al., 2007). However, human T cells were originally
shown to require IL-1 plus IL-23 or IL-6 to differentiate into Th17
cells and addition of TGF-b inhibits this polarization (Acosta-
Rodriguez et al., 2007; Wilson et al., 2007). More recent studies
described that TGF-b is required for Th17 cell generation from
naiveCD4+Tcells (Maneletal., 2008;Yangetal., 2008a).However,
the different roles of IL-1 for Th17 cell commitment in mouse and
human still remain elusive.Mice defective in IL-1R1 signaling were
reported tobe resistant to EAE and to exhibit a severe defect in the
generationof IL-17-producingTcells (Suttonetal., 2006), suggest-
ing that IL-1 is important for mouse Th17 cell regulation in vivo.
However, it was not clear from this study whether IL-1 signaling
in T cells was necessary for their differentiation into Th17 cells.
In the current study,weexamined the role of IL-1 inmurine Th17
cell regulation.Our resultsdemonstrate that IL-1signaling inTcells
was required for early Th17 cell differentiation in vitro and in vivo.
IL-1 regulated the expression of IRF4 and RORgt and overexpres-
sion of these two factors resulted in IL-1-independent Th17 cell
differentiation. Therefore, similar to the human system, IL-1 plays
a unique, nonredundant role during murine Th17 cell polarization.
RESULTS
IL-1R1 Expression Is Upregulated in Th17 Cells
In a search for genes upregulated in Th17 over Th1 cells, we
found that IL-1 receptor 1 (IL-1R1) mRNA was expressed at
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Figure 1. IL-1R1 Expression on Th17 Cells Is Critical for Induction of EAE
(A) CD25CD44loCD62hiCD4+ T cells (naive CD4+ T) were FACS sorted and polarized under Th1, Th2, or Th17 cell condition for 4 days.
(B) Naive CD4+ T cells were stimulated with anti-CD3 plus anti-CD28 in the presence of indicated cytokine for 24 hr before mRNA expression of IL-1R1 was
analyzed.
(C) FACS-sorted naive CD4+ T cells from WT or Stat3/, Rora/, or Rora/Rorc/ mice were cultured under Th17 cell condition for 4 days.
(D) Naive OT-II CD4+ T cells were activated with Ova peptide-pulsed splenic APCs under the neutral (anti-IL-4 and anti-IFN-g) and coinfected with two bicistronic
retroviruses expressing RORa-GFP or GFP vector and RORgt-hCD2 or hCD2. GFP+hCD2+ cells were FACS sorted.
In (A), (C), and (D), cells were restimulated with plate-bound anti-CD3 for 4 hr before mRNA expressionwas analyzed by real-time PCR. Data were normalized with
expression amounts of Actb (mean ± SD).
(E and F) CD4+ T cells were sorted fromWT or Il1r1/mice and i.v. transferred intoRag1/mice. The recipient micewere induced EAE and disease incidence (E)
and score (F) were measured daily and means ± SEM of all mice in each group were shown (F).
Data represent two independent experiments with consistent results. *p < 0.05; **p < 0.01 in comparison with WT recipients.higher amounts in Th17 cells when compared with Th1 cells
(data not shown). We then examined the expression of IL-1
receptor components in in vitro polarized Th1, Th2, and Th17
cells. We observed that IL-1R1 mRNA was highly expressed in
Th17 cells compared with Th1 and Th2 cells (Figure 1A). Expres-
sion of IL-1R-accessory protein (IL-1RAcP) was also moderately
increased. To understand the regulation of IL-1R1 expression,
we activated naive CD4+ T cells in the presence of anti-CD3
and anti-CD28 with or without IL-6, IL-23, or TGF-b. TCR and
costimulation signaling elevated IL-1R1 mRNA expression
(Figure 1B). Among the cytokines tested, IL-6 appeared to be a
critical factor for IL-1R1 upregulation whereas IL-23 or TGF-b
alone minimally affected its expression (Figure 1B).
Th17 cell differentiation requires several transcription factors
such as STAT3, RORa, and RORg (Ivanov et al., 2006; Yang
et al., 2007, 2008c). To determine whether these transcriptionfactors are required for IL-1R1 expression in CD4+ T cells, we
isolatednaiveCD4+Tcells frommicedefective in these transcrip-
tion factors and cultured them in a Th17 cell-polarizing condition
(Yang et al., 2007, 2008c). As shown in Figure 1C, IL-1R1 expres-
sion was severely impaired in Stat3/ T cells. Rora/ T cells
showed a moderate decrease in IL-1R1 expression and Rora/
Rorc/ T cells exhibited a more severe defect in IL-1R1 expres-
sion. Consistently, when we overexpressed RORa, RORg, or
both in T cells cultured under neutral conditions (Yang et al.,
2008c), bothRORaandRORg induced theupregulation of IL-1R1
mRNA in T cells (Figure 1D).
IL-1 Signaling in T Cells Is Necessary for Th17
Responses In Vivo
IL-1R1 is necessary for the induction of EAEdisease inmice (Brus-
tle et al., 2007),which couldbea result of defective IL-1 signaling inImmunity 30, 576–587, April 17, 2009 ª2009 Elsevier Inc. 577
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Figure 2. IL-1 Signaling in T Cells Is Required for Th17 Cell Development in EAE Model
Mixed bone marrow chimeric mice were generated and induced EAE. Mononuclear cells in central nervous system (CNS) and spleen were stained with anti-
CD45.2 to distinguish WT and Il1r1/ compartments and analyzed for CD4+ and CD11b+ cell presence (A), cytokine production profiles in CD4+ T cells after
PMA plus ionomycin (B and C) or MOG stimulation (B, only for spleen), or Foxp3+ cell in CD4+ T cells (D and E). The mice were divided into two groups based
on the disease severity (score, 0.5–2 for early phase; 2.5–4.0 for peak phase). *p < 0.05; **p < 0.01 in comparison withWT compartments. Mean values are shown
as horizontal bars (C and E). Data shown represent two independent experiments with consistent results.the innate immune system and/or in T cells. Because Th17 cells
highly express IL-1R1 and IL-1RAcP, we next sought to determine
the role of IL-1R1 in CD4+ T cells by adoptive transfer of CD4+
T cells from wild-type (WT) or Il1r1/ mice into Rag1/ mice.
Upon immunization with MOG, all recipient mice containing WT
T cells developed EAE whereas only 3 out of 8 (37.5%) mice with
Il1r1/ T cells developed EAE, with significantly delayed onset
(Figure 1E). Moreover, the severity of EAE was lower in mice with
Il1r1/ T cells than in those with WT cells (Figure 1F).
To illustrate more precisely the functional defects of Il1r1/
T cells in EAE, we generated mixed bone marrow (BM) chimeras
by transferring amixture ofCD45.1+WTandCD45.2+ Il1r1/BM
cells into sublethally irradiatedRag1/mice (Figure S1 available
online). Eight weeks later, we induced EAE in the recipient mice.
To analyze the T cell phenotypes during disease progression, we578 Immunity 30, 576–587, April 17, 2009 ª2009 Elsevier Inc.divided the EAEmice into two groups—early and peak phases—
based on the disease scores (score, 0.5–2 for early phase;
2.5–4.0 for peak phase). In CNS, the numbers of CD4+ T cells
were higher in WT population than in Il1r1/ population (9.1 3
104 ± 3.4 3 104 versus 3.3 3 104 ± 1.0 3 104 cells, p = 0.016),
whereas the numbers of CD11b+ macrophages were compa-
rable between the two populations (9.43 104 ± 1.33 104 versus
10.23 104 ± 1.63 104 cells, p = 0.105). Moreover, we observed
that WT CD4+ T cells contained a higher percentage of IL-17
producers compared to Il1r1/ CD4+ T cells (Figures 2B
and 2C). The percentage of IFN-g+IL-17+ cells was also remark-
ably higher inWT compared with the Il1r1/CD4+ T cell popula-
tion whereas the percentages of IFN-g+IL-17 cells were not
different. Moreover, the absolute numbers of IL-17-producing
WT CD4+ T cells were profoundly higher than those found in
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Figure 3. IL-1 Signal Is Required for Early Differentiation of Th17 Cells
(A) WT and Il1r1/ mice were subcutaneously immunized with KLH in CFA. Three or seven days later, lymphoid cells from draining lymph nodes were restimu-
lated with KLH overnight and IL-17- or IFN-g-expressing cells were measured by intracellular staining.
(B) FACS-sorted naive OT-II T cells from WT or Il1r1/ OT-II mice were intravenously transferred into congenic (CD45.1) mice. The recipient mice were immu-
nized with OVA323-339 peptide in CFA. Three days later, lymphoid cells from draining lymph nodes were restimulated with PMA plus ionomycin for 5 hr and IL-17-
or IFN-g-expressing cells were measured by intracellular staining. Data shown are on gated CD45.1+ CD4+ T cells.
(C and D) FACS-sorted naive CD4+ T cells fromWT or Il1r1/mice were cocultured with BM-derived DCs (WT) in the presence of soluble anti-CD3 Ab (0.2 mg/ml)
and LPS (100 ng/ml) plus TGF-b (1 ng/ml). IL-17- or IFN-g-expressing cells weremeasured by intracellular staining (C). On day 4, mRNA expression was assessed
by real-time RT-PCR after restimulation of T cells by anti-CD3 for 4 hr (D).
Data shown represent two independent experiments and normalized with expression amounts of Actb (mean ± SD).Il1r1/ CD4+ T cell population (Figure 2C). Because Treg cells
can also migrate into the inflamed CNS in a CCR6-dependent
manner (Yamazaki et al., 2008), we also analyzed the Treg cell
population by staining Foxp3. Of note, we observed a higher
percentage of Foxp3+ cells in Il1r1/ relative to WT population
and this pattern was more obvious in the inflamed CNS (Figures
2D and 2E). However, the absolute number of Foxp3+ T cells in
WT and Il1r1/ population was comparable because of the
lower percentage of total Il1r1/CD4+ T cell in the CNS (Figures
2A and 2E). Therefore, Il1r1/ CD4+ T cells migrated into the
inflamed tissue much less efficiently than did WT CD4+ T cells
and were defective in IL-17 production. Further examination of
MOG-reactive T cells in spleen revealed that IL-17- but not IFN-
g-expressing CD4+ T cells were also reduced in the Il1r1/ pop-
ulation (Figure 2B), suggesting that IL-1 signaling in CD4+ T cells
is necessary for proper Th17 cell differentiation in vivo.
IL-1 Signaling in T Cells Functions to Promote Early
Th17 Differentiation
Il1r1/ CD4+ T cells were defective in generating Th17 cells in
the EAEmodel. IL-1 signaling may mediate early Th17 cell differ-
entiation or the maintenance and expansion of polarized Th17
cells. To test these two possibilities, we immunized WT and
Il1r1/ mice with KLH in CFA and analyzed IL-17 and IFN-g-
producing cells upon ex vivo KLH restimulation. As depicted in
Figure 3A, as early as day 3, the Il1r1/ CD4+ T cell populationcontained a significantly lower frequency of IL-17+ cells
compared to WT. On day 7, increased percentages of IL-17+
cells were found in WT but not in Il1r1/ mice whereas the
percentage of IFN-g+ cells was comparable between WT and
Il1r1/ mice. The Th17-specific defect of Il1r1/ T cells was
confirmed with supernatants from KLH-restimulated spleno-
cytes (Figure S2). To directly ask whether the observed defect
in the early Th17 polarization is T cell intrinsic, we transferred
naive CD4+ T cells from either WT or Il1r1/ mice carrying the
chicken ovalbumin (OVA)-specific TCR transgene (OT-II) into
congenic mice and immunized the recipients with OVA323-339
peptide in CFA. As shown in Figure 3B, the frequency of IL-17-
producing WT OT-II T cells was significantly higher compared
with Il1r1/ OT-II cells within 3 days after immunization (15.07
± 4.06 versus 4.19 ± 2.35, p = 0.045). These data overall indicate
that the requirement of IL-1R1 signaling for early differentiation of
Th17 cells in vivo is CD4+ T cell intrinsic.
The above results suggest that IL-1 signaling is required in the
early phase of Th17 cell differentiation in vivo. This is surprising
considering that in vitro, IL-1 only moderately enhances Th17
cell differentiation in purified CD4+ T cells (Veldhoen et al.,
2006). We thus turned to a different Th17 cell differentiation
system in which T cells were cocultured with dendritic cells
(DCs) in the presence of soluble anti-CD3, LPS, and TGF-b (Veld-
hoen et al., 2006). Naive WT or Il1r1/ CD4+ T cells were acti-
vated with either WT or Il1r1/ bone marrow-derived DCs.Immunity 30, 576–587, April 17, 2009 ª2009 Elsevier Inc. 579
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Figure 4. Conversion of Foxp3+ T Cells into Th17 Cells Requires IL-1 Signal
(A) Mononuclear cells in EAE-induced mixed bonemarrow chimeric mice as described in Figure 2 were analyzed for IL-17 and Foxp3 expression. Data shown are
on gated CD4+ Foxp3+ cells. Mean values are shown as horizontal bars. **p < 0.01 in comparisonwithWT compartments. Data shown represent two independent
experiments with consistent results.
(B andC) FACS-sortedCD4+GFP+ cells fromnaiveFoxp3-GFP reportermicewere culturedwithDCsand in the presence of soluble anti-CD3, LPS, andTGF-bplus
anti-IL-1R1 or rat IgG as a control. IL-17- or GFP-expressing cells were measured by intracellular staining (B). On day 4, mRNA expression was assessed by real-
time RT-PCR after restimulation of T cells by anti-CD3 for 4 hr (C). mRNA expression in fresh FACS-sorted CD4+GFP+ cells, stimulated with anti-CD3 for 4 hr, was
used as a control.
Data shown represent two independent experiments and normalized with expression amounts of Actb (mean ± SD).Deficiency of IL-1R1 on T cells but not on DCs resulted in a great
reduction in all Th17 cytokines including IL-17, IL-17F, IL-22, and
IL-21 (Figure S3). Therefore, the IL-1 signal in CD4+ T cells rather
than DCs is required for Th17 cell generation.
To further address the role of IL-1 during early Th17 cell
commitment, we utilized the same DC-T cell coculture system
asdescribedaboveandexamined thekinetics of Th17cell gener-
ation. IL-17-producing T cells started to appear 2 days after
culture with evident difference in WT and Il1r1/ T cells and
thereafter (Figure 3C). Moreover, the staining intensity of anti-
IL-17 in WT cells was higher than that of Il1r1/ (mean fluores-
cence intensity on day 4,WT; 402 versus Il1r1/; 211), indicating
that WT Th17 cells are more potent IL-17 producers. Real-time
PCR analysis after anti-CD3 restimulation showed an efficient
induction of all Th17 cytokines (IL-17, IL-17F, IL-22, and IL-21)
in WT but not in Il1r1/ T cells (Figure 3D). These in vivo and
in vitro experiments together demonstrate that IL-1 signaling is
critical for the early differentiation stages of the Th17 cell lineage.
Conversion of Treg Cells into IL-17-Producing Cells
Requires IL-1 Signaling
In ourEAEstudywithmixedbonemarrowchimeras,weobserved
higher percentages of Foxp3+ T cells in the Il1r1/ population,580 Immunity 30, 576–587, April 17, 2009 ª2009 Elsevier Inc.compared with WT, particularly in the inflamed CNS (Figures 2D
and2E). This observation led us to hypothesize that IL-1 signaling
might be involved in a reciprocal regulation between Treg and
Th17 cells. IL-1 does not seem to be involved in the generation
of naturally occurring Foxp3+ Treg cells because naive Il1r1/
mice have normal numbers of Foxp3+ T cells in secondary
lymphoid organs (data not shown). Recent studies showed that
Foxp3+ T cells can be reprogrammed into IL-17-producing cells
(Yang et al., 2008b). To examine whether IL-1 signaling is neces-
sary for the conversion of Foxp3+ cells into IL-17-producing
T cells in vivo, we analyzed IL-17+ cells that coexpressed
Foxp3 in the CD4+ T cells from ourmixed BM-chimericmice after
EAE induction.We reasoned that IL-17+Foxp3+ T cells were likely
to be Treg cells on their way to become Th17 cells because very
few Foxp3+ T cells in naive mice produce IL-17. As shown in
Figure4A,10%of splenicandCNSFoxp3+WTTcells produced
IL-17 after EAE induction; however, this population was almost
completely absent within Il1r1/ Foxp3+ T cells in the same
animals.
To directly determine the role of IL-1 in the induction of IL-17 in
Foxp3+ T cells, we utilized Foxp3-GFP reporter mice (Fontenot
et al., 2005). CD4+GFP+ T cells from naive Foxp3-GFP reporter
mice were cultured with DCs in the presence of soluble anti-CD3,
Immunity
IL-1 Signaling in Th17 Cell DifferentiationLPS, and TGF-b. In some samples, we added anti-IL-1R1 in the
culture to block IL-1 signaling. IL-17+ cells started to appear on
day 2 after activation of Treg cells (Figure 4B). Blocking IL-1R1
greatly reduced the IL-17+ population, especially within the GFP+
(Foxp3+) population. This pattern became more apparent on
day 6 withmore than 50% reduction of IL-17+ cells in GFP popu-
lation and nearly 90% reduction inGFP+ population (Figure 4B). Of
note, little difference in GFP downregulation was observed
betweencells treatedwith control Ab and IL-1R1blockingAb, indi-
cating no role of IL-1 signaling in Foxp3downregulation. In support
of these data, real-time RT-PCR analysis revealed that Foxp3+
Treg cells after activation remarkably downregulated Foxp3 and
TGF-b1 expression with no difference between control Ab and
IL-1R1Ab treatment (Figure 4C). In contrast, those cultured in the
presence of control Ab expressed increased levels of RORg and
IRF4 transcripts whereas cells treated with IL-1R1 blocking Ab
did not.Moreover, the expression of IL-17, IL-17F, IL-22, and IL-21
was greatly increased in T cells in the absence of IL-1R1 blockade
(Figure 4C). The induction of Th17 cell transcription factors and
cytokines appeared to be specific as indicated by the fact that
T-bet and IFN-g expression remained largely unchanged.
Collectively, these data demonstrate that similar to naive
T cells, IL-1 signaling is critical for inducing the phenotypic
conversion of natural Treg into Th17 cells, which is independent
of Foxp3 downregulation.
IL-1 Signaling Maintains Th17 Cells in the Absence
of TCR Stimuli
The regulation of Th17 cell maintenance after initial differentiation
has not beenwell understood. IL-23 has been suggested as a key
factor required for Th17 cell maintenance rather than differentia-
tion (Veldhoenet al., 2006).On theother hand, IL-1R1expression,
similar to that of IL-23R, is also upregulated by IL-6 (Figure 1B),
raising the possibility that IL-1 signaling may have an additional
function in polarizedTh17 cells. To address this hypothesis, naive
CD4+ T cells from IL-17F-RFP reporter mice (Yang et al., 2008b)
were stimulated under Th17 cell conditions and RFP+ cells were
sorted to enrich Th17 cells. More than 50% of the sorted cells
expressed Th17 cytokines (IL-17, IL-17F) with less than 1% of
Foxp3+ cells and virtually no IFN-g+ cells (Figure 5A). These cells
were labeled with CFSE and cultured with IL-23 or IL-1 alone,
IL-23 plus IL-1, or IL-6 plus TGF-b in the absence of TCR stimula-
tion. Of interest, Th17 cells cultured with IL-1 but not IL-23 prolif-
erated in theabsenceof TCRstimulation,whichwasenhancedby
IL-23 (Figure5B, top).Comparedwith thestartingcells, Th17cells
cultured with medium alone produced reduced amounts of IL-17
and IL-17F (Figures 5A and 5B). In Th17 cells cultured with IL-23
alone or IL-6 plus TGF-b, there was no improvement over the
medium-only condition. However, addition of IL-1 to the culture
effectively maintained the cytokine production in Th17 cells
(Figure 5B). Moreover, Th17 cells cultured with IL-1 plus IL-23
exhibited enhanced maintenance of Th17 cytokine profiles.
None of the culture condition showed any increased expression
of IL-4, IFN-g (Figure 5B, bottom), or Foxp3 (data not shown).
Unexpectedly, in the above experiment, we detected
increased levels of IL-17, IL-17F, and IL-22 in the supernatants
from cells treated with IL-1 (Figure 5C). Therefore, polarized
Th17 cells produced Th17 cytokines upon IL-1 signal in the
absence of TCR stimulation. Consistent with intracellular stainingprofiles, IL-23 alone did not induce these Th17 cytokines but
greatly synergized with IL-1, especially in inducing IL-17 and
IL-22 secretion (Figure 5C). After anti-CD3 restimulation, cells
cultured with IL-1 alone or together with IL-23 produced Th17
cytokines at least comparable to original Th17 cells whereas
the other conditions failed to do so (Figure 5D). These observa-
tions indicate that IL-1 signaling not only maintains Th17 cell
phenotypes after polarization but also triggers Th17 cytokine
production even in the absence of TCR stimulation.
IL-1 Regulates Th17 Cell Differentiation in the Absence
of Exogenous TGF-b
Our in vivo and in vitro data thus far have revealed an essential
role of IL-1 signaling for early Th17 cell differentiation. However,
it was also shown that purified T cells differentiated into Th17
cells in the presence of TGF-b and IL-6. To better understand
the IL-1 effect on T cell polarization, we treated naive CD4+
T cells with anti-CD3 and anti-CD28 in the presence of defined
cytokine combination. In this experimental setting, IL-6 plus
TGF-b induced comparable IL-17+ cells between WT and
Il1r1/ T cells, indicating no autocrine effect of IL-1 in this condi-
tion. However, addition of IL-1 in WT but not Il1r1/ culture
greatly increased the IL-17+ population and induced higher
amounts of IL-17 as measured by mean fluorescence intensity
(Figure 6A). Because TGF-b is essential for Th17 cell commit-
ment, downregulation of Foxp3 by IL-21 or IL-6 is one of the
crucial steps during Th17 cell differentiation. Foxp3 induction
by TGF-bwas not hampered by addition of IL-1 (Figure 6B), sug-
gesting that IL-1 contributes to Th17 cell polarization via amech-
anism distinct from IL-6 and IL-21.
In the absence of exogenous TGF-b, IL-6 and IL-23 induced
only low levels of IL-17 production (Figure 6C), whereas IL-1
and IL-23 barely induced IL-17 (data not shown). However, the
combination of IL-6, IL-23, and IL-1 greatly induced IL-17+ cells
(Figure 6C). This was dependent on TGF-b as indicated by the
fact that neutralizing anti-TGF-b completely abolished IL-17
induction. Th17 cells generated by combination of IL-6, IL-23,
and IL-1 produced all Th17 cytokines (IL-17, IL-17F, IL-22)
whereas Th17 cells generated by IL-6+TGF-b produced little
amount of IL-22 (Figure 6D). Therefore, IL-1 synergizes with
IL-6 and IL-23 to induce Th17 cell differentiation at a low concen-
tration of TGF-b.
IL-1 Signaling Induces IRF4 and RORgt Expression
during Early Th17 Polarization
To understand the molecular mechanism by which IL-1 signaling
induces Th17 cell polarization, we stimulated naive CD4+ T cells
in the presence of anti-CD3 plus anti-CD28 with or without IL-1,
IL-6, and/or IL-23. Cells stimulated with IL-6 moderately upregu-
lated RORgt but not IRF4 expression; however, the combination
of IL-6 and IL-1 significantly increased the expression of these
transcription factors, particularly IRF4 (Figure 7A). The combina-
tion of IL-6, IL-1, and IL-23 further enhanced the expression of
RORa and Ahr.
The above data suggest that IL-1 may synergize with IL-6 to
induce IRF4 and RORgt expression during Th17 cell polarization.
To further test this idea, we compared gene expression of WT
and Il1r1/ CD4+ T cells during Th17 cell differentiation acti-
vated by DCs in the presence of LPS and TGF-b. Real-timeImmunity 30, 576–587, April 17, 2009 ª2009 Elsevier Inc. 581
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Figure 5. IL-1 Signal Expands and Maintains Th17 Cell Program in the Absence of TCR Stimulation
FACS-sorted naive CD4+ T cells from IL-17F-RFP reporter mice were stimulated under Th17 cell conditions (anti-IL-4, anti-IFN-g, IL-6, TGF-b, IL-23).
(A) On day 4, RFP+ cells were sorted and the expression of IL-17, IL-17F, IFN-g, Foxp3, or T-bet was analyzed by intracellular staining.
(B–D) The sorted RFP+ cells were labeled with CFSE and cultured with medium alone, IL-23, IL-1 alone, IL-23 plus IL-1, or IL-6 plus TGF-b for additional 3 days.
(B) IL-17-, IL-17F-, IL-4-, IFN-g-expressing cells were analyzed by intracellular staining after PMA plus ionomycin stimulation for 4 hr.
(C) Cytokines in the supernatant of 3 day additional culture were measured by ELISA.
(D) Cells were further restimulated with plate bound anti-CD3 overnight and cytokines in the supernatant were measured by ELISA. ‘‘Th17’’ designates the super-
natant of the sorted RFP+ cells after anti-CD3 overnight stimulation.
Values are the mean ± SEM (C and D). Data shown represent four independent experiments.582 Immunity 30, 576–587, April 17, 2009 ª2009 Elsevier Inc.
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Figure 6. IL-1 Signal Regulates Th17 Cell Cytokine Production in the Absence of Exogenous TGF-b
(A) FACS-sorted naive CD4+ T cells from WT or Il1r1/mice were stimulated with anti-CD3 and anti-CD28 plus anti-IL-4 and anti-IFN-g in the presence of indi-
cated cytokines for 4 days. IL-17-producing cells were analyzed by intracellular staining. Values are the percentage of IL-17+ cells and mean fluorescence inten-
sity (MFI) of the IL-17 staining of the gated cells.
(B) Foxp3- and T-bet-expressing cells were analyzed by intracellular staining.
(C) IL-17- and IFN-g-expressing cells were analyzed by intracellular staining.
(D) On day 4, cells stimulated under the condition described in (C) were harvested and restimulated with plated bound anti-CD3 overnight and cytokines in the
supernatant were measured by ELISA ([D], mean ± SEM). Data shown represent at least two independent experiments.RT-PCR analysis demonstrated comparable induction of RORa
in WT and Il1r1/ T cells (Figure 7B). In contrast, Il1r1/
T cells failed to express RORgt. Similarly, an almost complete
lack of IRF4 expression was observed in Il1r1/ T cells
compared with WT T cell as early as day 2 (Figure 7B). Moderate
increase in IL-23R expression was observed in WT but not in
Il1r1/ T cells (data not shown). In contrast, Foxp3 and Ahr
expression was higher in Il1r1/ T cells than those ofWT T cells.
We next asked whether overexpression of IRF4 and/or RORgt
in T cells would overcome IL-17 deficiency in Il1r1/ cells. We
utilized retroviral overexpression during the DC-T cell coculture.
Analysis of cytokine expression in T cells infected with empty
vector showed a great reduction of IL-17+ population in Il1r1/
T cells compared withWT T cells (Figure 7C). RORgt overexpres-
sion greatly improved the percentages of the IL-17-producing
population in both WT and Il1r1/ T cells. Interestingly, overex-
pression of IRF4 moderately increased the IL-17+ population in
Il1r1/ T cells, with little effect inWT T cells (Figure 7C). Because
weobservedseveredefects inbothRORgt and IRF4expression in
Il1r1/ T cells and overexpession of either one only partially
restored IL-17 production in Il1r1/ T cells, we further assessed
whether combined expression of IRF4 and RORgt induces IL-17
production in Il1r1/ T cells. After infection, dually infected cellswere sorted and analyzed. Again, overexpression of IRF4 alone
increased the IL-17+ population only in Il1r1/ but not in WT
Tcells (Figure7D). InWTTcells,RORgt overexpression increased
the IL-17+ population with no further increase by coexpression of
IRF4. In contrast, the IL-17+ population in Il1r1/ T cells was
remarkably higher under conditions where RORgt and IRF4
were coexpressed compared to RORgt or IRF4 single overex-
pressioncondition. Therefore,RORgt and IRF4cansynergistically
restore the Th17 cell polarization in the absence of IL-1R1 signal.
DISCUSSION
In the present study, we addressed the role of IL-1 in the Th17
cell lineage differentiation pathway. We found that Th17 cells
expressed higher amounts of IL-1R1 mRNA, which was depen-
dent on STAT3, RORa, and RORgt. Il1r1/ CD4+ T cells failed
to induce EAE, which was associated with a selective defect in
IL-17-producing T cells and an accumulation of Treg cells in the
inflamed tissue. IL-1R1 signal was required for the early differen-
tiation of Th17 cells and conversion of Foxp3+ T cells into IL-17-
producing cells. After polarization, IL-1 also allowed Th17 cells to
maintain their cytokine secretion profile. The IL-1R1 signaling in
T cells functioned by upregulating IRF4 and RORgt.Immunity 30, 576–587, April 17, 2009 ª2009 Elsevier Inc. 583
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Figure 7. IL-1R1 Signal Regulates Upregulation of RORgt and IRF4 Expression
(A) FACS-sorted naive CD4+ T cells from WT mice were stimulated with anti-CD3 and anti-CD28 plus anti-IL-4 and anti-IFN-g in the presence of indicated cyto-
kines for 4 days. mRNA expression was assessed by real-time RT-PCR.
(B) FACS-sorted naive CD4+ T cells fromWT or Il1r1/mice were cocultured with BM-derived DCs (WT) in the presence of soluble anti-CD3 and LPS plus TGF-b.
On days 2 and 4,mRNA expressionwas assessed by real-time RT-PCR. Data shown represent two independent experiments and are normalized with expression
amounts of Actb (mean ± SD).
(C and D) FACS-sorted naive CD4+ T cells fromWT or Il1r1/mice were cocultured with BM-derived DC (WT) in the presence of soluble anti-CD3 and LPS plus
TGF-b and infected with bicistronic retrovirus expressing GFP vector (RV-KM), RORgt-GFP, or IRF4-GFP. Four days after infection, IL-17- or IFN-g-expressing
cells were assessed by intracellular staining. Data shown are gated on GFP+ or GFP cells. Cells were coinfected with two bicistronic retroviruses expressing
IRF4-GFP or GFP vector and RORgt-hCD2 or hCD2 (D). GFP+ and hCD2+ cells were sorted and assessed by intracellular staining. Data represent two indepen-
dent experiments with consistent results.IL-1 is a pleiotropic cytokine with many target cells. Although
IL-1 was shown previously to be important in Th17 cell genera-
tion in vivo, its exact action has not been understood. Higher584 Immunity 30, 576–587, April 17, 2009 ª2009 Elsevier Inc.IL-1R1 expression on Th17 cells has been observed in the
SKG mouse strain that spontaneously develops arthritis (Hirota
et al., 2007). On the other hand, IL-1R1 expression on DCs has
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(Eriksson et al., 2003), a Th17 cell-mediated autoimmune
disorder (Rangachari et al., 2006). In our study, we clearly
demonstrated that IL-1R1 expression in CD4+ T cells but not
on DCs is critically required for Th17 cell generation in vitro.
Moreover, Rag1/ mice receiving Il1r1/ CD4+ T cells dis-
played significantly attenuated EAE compared with recipients
of WT T cells. Taken together, these observations indicate that
IL-1 responsiveness in T cells is required for Th17 cell develop-
ment and Th17 cell-mediated autoimmunity.
The regulation of IL-1R1 expression has not been well under-
stood. In the current study, we show that although TCR plus
costimulation activation resulted in elevated IL-1R1 mRNA
expression, IL-6, but not IL-23 or TGF-b, serves a unique role
to further enhance its expression. Consistent with this observa-
tion, IL-1 functioned only in the presence of IL-6 in upregulating
Th17 cell-specific genes. IL-6 is an essential Th17 cell priming
cytokine—it can not only initiate Th17 cell differentiation and
downregulate Foxp3 expression, but it also has been shown to
allow CD4+ T cells to produce IL-21 (Nurieva et al., 2007; Zhou
et al., 2007) and respond to IL-1 and IL-23 (Yang et al., 2007;
Zhou et al., 2007). Interestingly, naive CD4+ T cells stimulated
with IL-6, IL-23, and IL-1 can be differentiated into Th17 cells
in the absence of exogenous TGF-b. Although this type of
Th17 cell differentiation is still dependent on TGF-b, most likely
from T cell itself or contained in serum, it led to greater IL-22
expression than those polarized by only TGF-b and IL-6. This
finding suggests flexibility of Th17 cell differentiation. As previ-
ously shown in the literature, Th17 cells can be generated in
the presence of IL-6 and relatively high concentrations of TGF-b,
which could be found at sites such as the intestine or tumor
microenvironment. On the other hand, with low TGF-b concen-
trations but with strong innate responses, IL-1, along with the
other proinflammatory cytokines, can also drive Th17 cell polar-
ization. This idea is supported by the early defect of Th17 cell
differentiation in vivo in the absence of IL-1 signaling. However,
the function and regulation of Th17 cells generated by these two
different conditions remain to be understood. Interestingly, IL-1-
induced IL-22 expression in Th17 cells differentiated in the pres-
ence of exogenous TGF-b, suggesting the plasticity of IL-22
expression. Most importantly, our results also indicate that
similar to human Th17 cells, mouse Th17 cells can be developed
in the presence of proinflammatory cytokines IL-6, IL-1, and
IL-23 in the absence of exogenous TGF-b.
IL-23 has been suggested to support Th17 cell expansion and
maintenance (Veldhoen et al., 2006). In the present study, we
observed that IL-1 regulates early Th17 cell differentiation and
maintenance of polarized effector Th17 cells. For the latter, IL-1
may have an overlapping function with IL-23. However, IL-23
alone had little effect on Th17 cells in the absence of TCR stim-
ulation whereas the combination of IL-1 and IL-23 greatly syner-
gized to expand Th17 cells and maintain their cytokine profiles.
As Il1r1/ T cells expressed lower IL-23R, IL-1 may function
to enhance the IL-23R expression on Th17 cells. Nevertheless,
the expansion and cytokine production of Th17 cells by IL-1 in
the absence of TCR stimulation suggests an important role of
IL-1 in the homeostatic maintenance of Th17 cells. Because
tissue inflammation induces abundant IL-1 and IL-23 expres-
sion, it would be interesting to surmise that Th17 cells that arenot antigen specific in inflamed tissue might expand and
produce Th17 cytokines in a TCR-independent manner, and
thus aggravate tissue damage. Further in vivo studies will clarify
the role of inflammatory cytokines on Th17 cells.
A recent study demonstrates that IRF4 is necessary for Th17
cell differentiation. Irf4/ T cells fail to produce IL-17 in Th17
cell conditions but produces IFN-g in Th1 cell conditions (Brustle
et al., 2007).Moreover, overexpression of RORgt in Irf4/ T cells
only partially restores IL-17 production (Brustle et al., 2007). The
physiological factor(s) regulating IRF4 induction during Th17 cell
polarization has been unclear. In the present study, we utilized
a DC-T cell coculture system and observed a severe defect in
IRF4 expression in Il1r1/ T cells compared toWT T cells. Over-
expression of IRF4 or RORgt alone partially overcame Th17 cell
polarization in Il1r1/ T cells. Interestingly, coexpression of
these two transcription factors enhanced Th17 cell polarization
in Il1r1/ but not in WT T cells. Therefore IL-1 from activated
antigen-presenting cells delivers signals to T cells to upregulate
IRF4 and RORgt during their early lineage programming and to
sustain their differentiation. The present study unveiled IL-1 as
a critical factor for inducing IRF4 in CD4+ T cells during Th17
cell polarization. Lack of an effect after IRF4 overexpression in
WT T cells is probably because IRF4 expression in WT T cells
after stimulation by TCR and DCs was sufficient for Th17 cell
polarization.
The balance between Treg and Th17 cells is important for the
generation of immunity against extracellular bacteria and regu-
lating autoimmunity. Recent studies by our own group and
others showed a physical interaction between Foxp3 and RORgt
or RORa (Yamazaki et al., 2008; Yang et al., 2008b; Zhou et al.,
2008). Of note, Foxp3+ cells can produce IL-17 in response to
inflammatory stimuli. In the mixed bone marrow chimera study,
we observed a higher percentage of Foxp3+ T cells in the
Il1r1/ population compared with the WT population in the in-
flamed CNS. More importantly, about 10% of Foxp3+ WT
T cells in CNS and spleen expressed IL-17 whereas nearly no
Foxp3+ Il1r1/ T cells expressed IL-17. It has been reported
that Foxp3+ IL-17F+ cells are much less efficient in suppressing
the activation of naive T cells (Yang et al., 2008b). Therefore, the
IL-1R1 signal is critically required for Foxp3+ T cells to produce
IL-17. However, IL-1 did not affect the downregulation of
Foxp3 or the TGF-b-induction of Foxp3, indicating that the
mechanism of IL-1-mediated IL-17 expression is distinct from
that of IL-6. IL-1R1 delivers a signal through the recruitment of
MyD88 and TRAF6 leading to the activation of NF-kB and
MAPK pathways, which is distinct from IL-6 and IL-23 signaling.
This may explain the synergism of IL-1 with the other Th17 cell-
inducing factors and their different effects on Foxp3, RORa, and
RORgt. Ahr was recently discovered as a critical transcription
factor for both Treg and Th17 cells. Of note, we observed higher
Ahr expression in the Il1r1/ T cells, suggesting an inhibitory
role of IL-1 on Ahr. The precise regulation by IL-1 signaling on
Ahr expression remains to be determined.
The present study unveiled the critical roles of IL-1 during early
Th17 cell differentiation, expansion, and maintenance. Our
results may explain the molecular mechanism of the sponta-
neous arthritis onset in IL-1Ra-deficient mice, which is a Th17-
mediated autoimmune disorder (Nakae et al., 2003). Of interest,
a recent study showed that administration of ATP, a well-knownImmunity 30, 576–587, April 17, 2009 ª2009 Elsevier Inc. 585
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gut (Atarashi et al., 2008), suggesting a role of IL-1 for the gener-
ation of Th17 cells in the gut. Our data corroborate these find-
ings. The identification of IL-1 as a key regulator of Th17 cell
biology may provide support for therapeutic targeting of IL-1 in
autoimmune disorders.
EXPERIMENTAL PROCEDURES
Mice
C57BL/6, OT-II, B6.SJL (CD45.1), Il1r1/, and Rag1/mice were purchased
from Jackson Laboratory. Foxp3-GFP reporter micewere generously provided
by A. Rudensky (University of Washington) (Fontenot et al., 2005). IL-1R1-defi-
cient andOT-II micewere bred to yield Il1r1/OT-II mice. HeterozygousStag-
gerer (Rorasg/+) mice and Rorasg/sgRorc/ mice were obtained as described
(Yang et al., 2008c). Stat3 fl and Tie2-Cre mice were bred to yield Stat3f/D
Cre+ as described (Panopoulos et al., 2006; Yang et al., 2007). IL-17F-RFP
reporter mice were generated as described (Yang et al., 2008b). The animal
experimentswere performed at the ageof 6–10weekswithprotocols approved
by Institutional Animal Care and Use Committee.
Adoptive Transfer and Mixed Bone Marrow Chimera Studies
CD4+T cells fromC57BL/6 or Il1r1/micewere sortedbyAutoMacs and intra-
venousely transferred intoRag1/mice (73 106 cells/transfer). One day later,
the recipient mice were induced EAE. To generate mixed bone marrow
chimera, T cell-depleted bone marrow cells were obtained from C57BL/6 or
Il1r1/ mice and mixed 1:1 ratio before being transferred into irradiated
Rag1/mice (103 106 cells/transfer, 750 rad). Eight weeks later, the recipient
mice were induced EAE.
In some experiments, we isolated naive CD4+ T cells from either wild-type
OT-II or Il1r1/ OT-II mice (CD45.2) and transferred into congenic mice
(CD45.1). The recipients were immunized with OVA323-339 peptide in CFA.
Three days later, lymphoid cells from the draining lymph nodes of the recipi-
ents were stimulated with phorbol 12-myristate 13-acetate (PMA) plus iono-
mycin in the presence of Golgi-stop for 4 hr, after which CD45.2+ CD4+ cells
were analyzed for intracellular IL-17 and IFN-g.
EAE Induction
Mixed bone marrow chimeras and CD4+ T cell reconstituted Rag1/ mice
were immunized subcutaneously at the dorsal flanks with 150 mg of MOG
peptide emulsified in CFA at day 0 and day 7. Pertussis toxin was given intra-
peritoneally at day 1 and day 8 (500 ng/injection). Signs of EAE were assigned
scores on a scale of 1–5 as follows: 0, none; 1, limp tail or waddling gait with tail
tonicity; 2, wobbly gait; 3, hind-limb paralysis; 4, hind-limb and forelimb paral-
ysis; 5, death. Disease incidence and scores weremeasured daily. For analysis
of central nervous system infiltrates, both brain and spinal cord were collected
from perfused mice, and mononuclear cells were prepared with 37% percoll
gradient.
T Cell Differentiation
Dendritic cell and T cell coculture system was adopted from previous study
(Veldhoen et al., 2006). In brief, naive CD4+CD25CD62LhiCD44lo T cells
from C57BL/6 and IL-1R1-deficient mice were FACS sorted and activated
with 0.2 mg/ml anti-CD3 and bone marrow-derived DCs in the presence or
absence of 1 ng/ml TGF-b (Peprotech), 100 ng/ml LPS. For anti-CD3/CD28-
stimulated differentiation, naive CD4+ T cells were activated with plate-bound
1 mg/ml anti-CD3 and 1 mg/ml anti-CD28 and in the presence of 5 ng/ml TGF-b
(Peprotech), 40 ng/ml IL-6 (Peprotech), 50 ng/ml IL-23 (R&D systems), 5 mg/ml
anti-IL-4 (11B11), 5 mg/ml anti-IFN-g (XMG 1.2), 10 ng/ml IL-1b (Peprotech),
10 ng/ml IL-1a (Peprotech), or combination of these stimuli (in some experi-
ments, 10mg/ml of anti-IL-2 or anti-TGF-bwasused). Four days after activation,
cells were washed and restimulated with plate-bound anti-CD3 (2 mg/ml) over-
night and cytokines in the supernatant were measured by ELISA. For intracel-
lular staining, cells were stimulated with PMA and ionomycin in the presence of
Golgi-stop for 4 hr, after which IL-17- and IFN-g-producing cells were analyzed
with intracellular staining. Intracellular staining for Foxp3 or T-bet was per-586 Immunity 30, 576–587, April 17, 2009 ª2009 Elsevier Inc.formed with a Foxp3 staining kit (eBioscience) and PE-conjugated anti-T-bet
Ab (Santa Cruz).
Quantitative Real-Time RT-PCR
Total RNA was prepared from T cells with TriZol reagent (Invitrogen). Comple-
mentary DNA (cDNA) was synthesized with Superscript reverse transcriptase
and oligo(dT) primers (Invitrogen), and gene expression was examined with
a Bio-Rad iCycler Optical System with iQ SYBR green real-time PCR kit (Bio-
Rad Laboratories). The data were normalized to Actb reference. The following
primer pairs were used: IL-1R1; forward, 50-TGGAACAGAGCCAGTGTCAG-30,
reverse, 50-CAGGAGAAGTCGCAGGAAGT-30, IL-1RAcP; forward, 50-TTGCCA
CCCCAGATCTATTC-30, reverse, 50- CCAGACCTCATTGTGGGAGT-30, IRF4:
forward, 50-TCCTCTGGATGGCTCCAGATGG-30, reverse, 50-CACCAAAGCA
CAGAGTCACCTG-30, TGF-b1; forward, 50-GCAACATGTGGAACTCTACCA
GA-30, reverse, 50-GACGTCAAAAGACAGCCACTCA-30. The primers for Ifng,
Il17, Il17f, Il23r, Il22, Il21, Rora, Foxp3, Rorc, Tbx21, and Actb were previously
described (Nurieva et al., 2007; Yang et al., 2008c).
Retroviral Transduction
Genes encoding IRF4 (GenBank accession number NM013674) and RORgt
(GenBank accession number AJ132394) were cloned into bicistronic retroviral
vector pGFP-RV (Ouyang et al., 1998) or pMIG-hCD2 (Deftos et al., 1998)
containing IRES-regulated GFP and human CD2, respectively. CD4+
CD25CD62LhiCD44lo T cells from C57BL/6 and Il1r1/ mice were FACS
sorted and activated with 0.2 mg/ml anti-CD3 and bone marrow-derived DCs
in the presence or absence of 1 ng/ml TGF-b (Peprotech) and 100 ng/ml LPS
(Veldhoen et al., 2006). Twenty-four hours after activation, the cells were
infected by retroviruses expressing IRF4-GFP, RORgt-GFP, or control empty
vector (containing only IRES-GFP). Four days after infection, the cells were
restimulated with PMA and ionomycin in the presence of Golgi-stop for 4 hr,
after which IL-17- and IFN-g-producing cells were analyzed with intracellular
staining on a GFP+ gate. Coinfection was performed with two bicistronic retro-
viruses expressing IRF4 or empty vector (both have IRES-GFP) and RORgt or
control vector (both with IRES-hCD2). The analysis was performed on
aGFP+hCD2+gate. RORaandRORgt single or double infectionwasperformed
as described (Yang et al., 2008c).
Statistics
The Kaplan-Meier method was used to determine the EAE incidence in CD4+
T cell transfer models, and the log-rank test was used for statistical analysis.
The Student’s t test was used to assess all other statistical values. p values
were determined, and error bars represent standard error of the mean (SEM).
SUPPLEMENTAL DATA
Supplemental Data include three figures and can be found with this article
online at http://www.immunity.com/supplemental/S1074-7613(09)00142-3.
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